Chemoinformaics analysis of 4-Ethyl-1,2-dimethoxybenzene
| Molecular Weight | 166.22 | nRot | 3 |
| Heavy Atom Molecular Weight | 152.108 | nRig | 0 |
| Exact Molecular Weight | 166.099 | nRing | 1 |
| Solubility: LogS | -7.165 | nHRing | 0 |
| Solubility: LogP | 8.824 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 26 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 27.6391 |
| nHD | 0 | BPOL | 17.5169 |
| QED | 0.29 |
| Synth | 1.083 |
| Natural Product Likeliness | 0.144 |
| NR-PPAR-gamma | 0.093 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0 |
| HIA | 0.002 |
| CACO-2 | -4.812 |
| MDCK | 0.00000793 |
| BBB | 0.085 |
| PPB | 0.982867 |
| VDSS | 3.961 |
| FU | 0.0152473 |
| CYP1A2-inh | 0.227 |
| CYP1A2-sub | 0.186 |
| CYP2c19-inh | 0.354 |
| CYP2c19-sub | 0.068 |
| CYP2c9-inh | 0.094 |
| CYP2c9-sub | 0.95 |
| CYP2d6-inh | 0.276 |
| CYP2d6-sub | 0.053 |
| CYP3a4-inh | 0.191 |
| CYP3a4-sub | 0.042 |
| CL | 4.492 |
| T12 | 0.058 |
| hERG | 0.248 |
| Ames | 0.007 |
| ROA | 0.032 |
| SkinSen | 0.954 |
| Carcinogencity | 0.033 |
| EI | 0.936 |
| Respiratory | 0.488 |
| NR-Aromatase | 0.045 |
| Antiviral | No |
| Prediction | 0.886447 |